sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Investment Update on Mural Oncology
The Vanguard Group, Inc., a significant investor in Mural Oncology plc, reported its investment position as part of the Irish Takeover Panel regulations. The disclosure, dated August 14, 2025, reflects the company's interests in the securities of Mural Oncology, highlighting their importance as a stakeholder.
The Vanguard Group holds 771,891 ordinary shares of Mural Oncology, representing a 4.47% stake. This disclosure ensures transparency in financial engagements concerning potential takeover dealings. The transactions reported included a purchase and sale of shares at a price of 1.79 USD per unit.
No additional cash-settled or stock-settled derivative positions have been disclosed. Furthermore, the company reported no indemnity, option arrangements, or agreements impacting its position regarding Mural Oncology shares. This disclosure underscores the absence of any hidden commitments or intent to alter voting rights related to their current shareholding.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.